Milestone Scientific Inc (MLSS, Financial) is set to release its Q3 2024 earnings on Nov 15, 2024. The consensus estimate for Q3 2024 revenue is $2.61 million, and the earnings are expected to come in at -$0.01 per share. The full year 2024's revenue is expected to be $9.57 million and the earnings are expected to be -$0.04 per share. More detailed estimate data can be found on the Forecast page.
Milestone Scientific Inc (MLSS, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Milestone Scientific Inc (MLSS) for the full year 2024 have declined from $10.30 million to $9.57 million. For 2025, the estimates have decreased from $11.85 million to $11.37 million. Earnings estimates for the full year 2024 have improved from -$0.05 per share to -$0.04 per share, and for 2025, the estimates have also increased from -$0.05 per share to -$0.04 per share.
Milestone Scientific Inc (MLSS, Financial) Reported History
In the previous quarter of 2024-06-30, Milestone Scientific Inc's (MLSS) actual revenue was $1.85 million, which missed analysts' revenue expectations of $2.52 million by -26.52%. Milestone Scientific Inc's (MLSS) actual earnings were $0.00 per share, which beat analysts' earnings expectations of -$0.01 per share by 100%. After releasing the results, Milestone Scientific Inc (MLSS) was down by -2.96% in one day.
Milestone Scientific Inc (MLSS, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 2 analysts, the average target price for Milestone Scientific Inc (MLSS) is $2.13 with a high estimate of $3.00 and a low estimate of $1.25. The average target implies an upside of 217.16% from the current price of $0.67.
Based on GuruFocus estimates, the estimated GF Value for Milestone Scientific Inc (MLSS, Financial) in one year is $0.93, suggesting an upside of 38.81% from the current price of $0.67.
Based on the consensus recommendation from 2 brokerage firms, Milestone Scientific Inc's (MLSS, Financial) average brokerage recommendation is currently 2.0, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
